Home

Brooke Story

CIK 1866136 · last filed 2026-07-17

Brooke Story is a corporate insider who has filed 11 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for PYPD, was dated Jul 17, 2026. Across all open-market trades the lifetime net is −$13.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $783.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$783.1K

Companies

3

Total Filings

11

Lifetime Open-Market Net

-$13.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PYPD Director — $4.84 — $0 1 2026-07-17
LIVN Director 10,274 $76.22 $783.1K -$13.5K 7 2026-06-17
Sigilon Therapeutics, Inc. (SGTX) Delisted Director — $22.47 — $0 2 2022-05-27

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-17 PYPD Grant (A) — $0 EDGAR
2026-06-17 LIVN Mixed +3,556 -$38.7K EDGAR
2025-11-19 LIVN Sell (S) −250 -$13.5K EDGAR
2025-11-18 LIVN Notice (144) −250 -$13.5K EDGAR
2025-06-17 LIVN Mixed +3,006 -$18.8K EDGAR
2024-06-18 LIVN Mixed +2,096 -$30.8K EDGAR
2023-09-19 LIVN Mixed +1,380 -$19.9K EDGAR
2023-06-20 LIVN Grant (A) — $0 EDGAR
2022-09-19 LIVN Grant (A) — $0 EDGAR
2022-05-27 Sigilon Therapeutics, Inc. (SGTX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.